Astera Labs, Inc. $ALAB Stock: M & L Capital Management Ltd Increases Position

M & L Capital Management Ltd boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 8.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 50,200 shares of the company’s stock after purchasing an additional 4,000 shares during the quarter. Astera Labs accounts for 3.7% of M & L Capital Management Ltd’s investment portfolio, making the stock its 14th largest position. M & L Capital Management Ltd’s holdings in Astera Labs were worth $17,870,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in ALAB. BlackRock Inc. acquired a new stake in shares of Astera Labs in the 2nd quarter worth $6,609,581,000. Bank of America Corp DE purchased a new position in shares of Astera Labs during the 2nd quarter worth $1,061,791,000. Atreides Management LP raised its holdings in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the period. Amundi boosted its position in shares of Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after acquiring an additional 823,477 shares during the last quarter. Finally, Deutsche Bank AG acquired a new position in shares of Astera Labs during the 2nd quarter valued at about $325,602,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the sale, the director owned 253,863 shares in the company, valued at $71,114,642.19. This represents a 41.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares in the company, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $127,306,034 over the last three months. Company insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ALAB. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Friday, October 9th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Morgan Stanley lifted their target price on shares of Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Barclays lifted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Finally, TD Cowen decreased their target price on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating on the stock in a report on Monday, October 19th. Eleven equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $340.79.

Astera Labs Trading Up 10.5%

NASDAQ ALAB opened at $286.69 on Wednesday. The stock has a fifty day simple moving average of $308.85 and a 200-day simple moving average of $253.21. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the firm posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 2.71 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.